GPT and metabolic dysfunction-associated steatotic liver disease: As shown in Table 2, we analyzed the effect of NHR on CAP and NAFLD/MASLD using weighted multiple regression models adjusted for all possible confounding variables (age, gender, race, smoking, diabetes, hypertension, history of CVD, BMI, TC, ALT, and uric acid).